| Document |
Document Title |
|
WO/2007/071441A1 |
A compound of formula (I), wherein the residues have various meanings, useful as pharmaceuticals.
|
|
WO/2007/068894A2 |
The invention relates to substituted diphenylethers, -amines, -sulfides, and -methanes as useful pharmaceutical compounds for treating respiratory- disorders, pharmaceutical compositions containing them, and processes for their preparation.
|
|
WO/2007/067817A1 |
The present invention provides compounds having the structure of Formula (I), wherein R1 is optionally substituted lower alkyl, optionally substituted cycloaikyl, or optionally substituted aryl; R2 is hydrogen, carboxyalkyl, optionally s...
|
|
WO/2007/063028A2 |
The invention relates to methods for producing sulfonamides of formula I, wherein the variables have the designations cited in the description, by reacting m-nitro-benzoic acid chlorides of formula II with aminosulfons of formula III, un...
|
|
WO2007043274A9 |
Polyarylene comprising a dihalobenzene compound represented by the formula (1): (1) (wherein A represents an alkoxy group having 3 to 20 carbon atoms or the like, R1 represents a hydrogen atom, a fluorine atom, an alkyl group having 1 to...
|
|
WO/2007/060215A2 |
The present invention relates to selected (R)-arylalkylamino derivatives of formula (I), in which R, R1 and Ar are as defined in the claims. These compounds show a surprising potent inhibitory effect on C5a induced human PMN chemotaxis. ...
|
|
WO/2007/060220A2 |
The present invention relates to a method of combating animal pests which comprises contacting the animal pests, their habit, breeding ground, food supply, plant, seed, soil, area, material or environment in which the animal pests are gr...
|
|
WO/2007/061637A2 |
A gemini surfactant represented by the formula wherein: each Rf independently represents perfluorobutyl or perfluoropropyl; each R1 independently represents alkyl having from 1 to 6 carbon atoms; L1 and L2 represent alkylene having from ...
|
|
WO/2007/058960A1 |
Novel sulfamoyl benzamide compounds, pharmaceutical compositions containing the sulfamoyl benzamide compounds, and methods of their pharmaceutical use are disclosed. In certain embodiments, the sulfamoyl benzamide compounds are agonists ...
|
|
WO/2007/058639A2 |
D-(threo)-1-aryl-2-disubstitutedacylamido-3-fluoro-1-propano
l compounds compounds and analogues thereof (“Fenicol Compounds”), compositions comprising an effective amount of a Fenicol Compound, and methods for treating or preventing...
|
|
WO/2007/054139A2 |
Objects of the present invention are the compounds of formula (I) Their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above compounds, medicaments containing them and their ...
|
|
WO/2007/054257A2 |
The present invention makes reference to new indene derivatives with general formula (I), as well as to their preparation procedures, their application as medicament and the pharmaceutical compositions containing them. The new compounds ...
|
|
WO/2007/056469A2 |
Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins are disclosed.
|
|
WO/2007/052831A1 |
A compound represented by the formula (I): wherein Ar represents a group represented by the formula: (wherein Y represents methylene or an oxygen atom, R1 represents aminosulfonyl, C1-6 alkylaminosulfonyl, C1-6 alkylcarbonylamino or C1-6...
|
|
WO/2007/048557A1 |
Compounds of the formula (I), wherein R1, R2, X and N are as defined in the specification; L is F, NH2, NHAlk or N(Alk)2 n is 1 or 2; A' and A" are terminal groups as defined in the specification. The compounds have utility as HIV-1 prot...
|
|
WO/2007/045573A1 |
The present invention provides for compounds useful for treating an HIV infection, or preventing an HIV infection, or treating AIDS or ARC. The compounds of the invention are of formula I wherein R1-R4 and Ar are as herein defined. Also ...
|
|
WO/2007/047432A1 |
Compounds as modulators of peroxisome proliferator activated receptors, pharmaceutical compositions comprising the same, and methods of treating disease using the same are disclosed.
|
|
WO/2007/045893A2 |
The invention provides a pharmacophore for identifying or designing an agonist that binds to a beta-3 adrenergic receptor, wherein the pharmacophore requires the following features: (a) a hydrogen accepting group adjacent to an aromatic ...
|
|
WO/2007/045572A1 |
The present invention provides for compounds useful for treating an HIV infection, or preventing an HIV infection, or treating AIDS or ARC. The compounds of the invention are of formula I wherein R1, R2, R3, R4, R5 and X are as herein de...
|
|
WO/2007/042817A1 |
There is provided compounds of formula (I), wherein R1, R2, X2, X4 and X5to X8 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibi...
|
|
WO/2007/039736A1 |
The invention relates to substituted phenylacetic acids as useful pharmaceutical compounds for treating respiratory disorders, pharmaceutical compositions containing them, and processes for their preparation.
|
|
WO/2007/039125A2 |
The invention provides an optically active form of the compound of formula (I), or a pharmaceutically acceptable ester, amide, solvate or salt thereof, including a salt of such an ester or amide, and a solvate of such an ester, amide or ...
|
|
WO/2007/037242A1 |
Disclosed is a method for producing an optically active benzylamine derivative which is useful as an intermediate for pharmaceutical products and the like. Specifically, an optically active benzylsulfonylamide derivative as a novel compo...
|
|
WO/2007/034035A1 |
The invention relates to sulphonamide derivatives of formula (I), where Rc is selected from a group consisting of dialkylamino, NO2, CN, aminocarbonyl, monoalkylaminocarbonyl, dialkylaminocarbonyl, alkanoyl, oxazol-2-yl, oxazolylaminocar...
|
|
WO/2007/031608A1 |
The present invention relates to a refined and detailed molecular model of the α2β1 integrin l-domain, especially the MIDAS and to the use of such a model for designing novel integrin modulators, especially α2β1 integrin modulators. ...
|
|
WO/2007/031823A1 |
The invention relates to an process for preparing Tamsulosin hydrochloride of Formula (I) which comprises (i) reacting (R)-(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide of Formula (II) with substituted phenoxy compound of Formula (II...
|
|
WO/2007/032362A1 |
It is intended to provide a substituted cycloalkene derivative represented by the general formula (I) which has an action of suppressing intracellular signal transduction or cell activation caused by endotoxin and a cell response such as...
|
|
WO/2007/030761A2 |
This invention relates to novel compounds useful in the treatment of diseases associated with TRPV4 channel receptor. More specifically, this invention relates to certain acyclic diamines, which are agonists of TRPV4 channel receptors.
|
|
WO/2007/025575A1 |
A compound of Formula (I).
|
|
WO/2007/027524A2 |
Aromatic N-halosulfonamide organic compounds have been known for over one hundred years. The ability of these compounds to release active halogen ions has been utilized in a range of biocidal and fungicidal applications. The most widely ...
|
|
WO/2007/022624A1 |
The present invention relates to the field of sulfonylimides and derivatives thereof Pn particular, it relates to processes for preparing compounds of formula (I) wherein each of the R1 groups is independently F, Cl, Br or I, and R2 is H...
|
|
WO/2007/024611A2 |
The present invention provides wherein R1 is selected from the group consisting of C1-C10 alkoxy, OH and NR4R5; R2 is selected from the group consisting of C1-C10 alkyl and (CH2)nOH; R3 is selected from the group consisting of C1C10 alky...
|
|
WO/2007/024860A2 |
The present invention provides R, R1, R2, R3, X, c, d, e, f, g, x, y, a, b, z and n are defined in the specification. These compounds are useful in lowering IOP and/or treating glaucoma or providing neuroprotection to the eye of a human ...
|
|
WO/2007/020636A1 |
The present invention provides compounds of the general formula I, and uses thereof for printing electronic components such as wires, resistors and LEDs.
|
|
WO/2007/017511A2 |
The invention relates to substituted 1,2-ethylenediamines of general formula (I), wherein the radicals R1 - R13, A, B, L and i are as defined in the description and the claims. The invention also relates to the use thereof for treating A...
|
|
WO/2007/014847A1 |
Storage-stable compositions comprising a colour developer, an anionic dispersant and a thickening agent as well as heat-sensitive recording materials comprising such compositions, a process for its manufacture and its use.
|
|
WO/2007/015724A1 |
An improved valproic acid salt, the tromethamine salt of valproic acid (TRIS-valproate) is disclosed. TRIS-valproate provides superior stability, storage, tableting and patient tolerance. A crystalline form of TRIS-valproate, a method of...
|
|
WO/2007/015809A2 |
Compounds having the structure: are HIV reverse transcriptase inhibitors, wherein A, X, Y, Z, R1 and R2 are defined herein. The compounds and their pharmaceutically acceptable salts are useful in the inhibition of HIV reverse transcripta...
|
|
WO/2007/013929A1 |
Aniline sulfonamide derivatives according to formula I have therapeutic utility, particularly in the treatment of diabetes, obesity and related conditions and disorders: where R1, R2, R3, R4, R5, R6, and L are set forth in the description.
|
|
WO/2007/010356A2 |
The invention relates to a process for the preparation of compounds of formula (I) wherein Q1 is a group selected from formulae (II) & (III) and a group *-NR6 -Q2-A or, if appropriate, their pharmaceutically acceptable salts and/or isome...
|
|
WO/2007/009798A2 |
A process of producing a compound of formula (3), wherein R1 is a C1-5alkyl group, R2 is a halogen atom, a C1-5 alkyl group, a C2-5 alkenyl group, a C2-5 alkynyl group, a C1-5 alkyl group, a C1-5 alkoxy group, a nitro group, or a hydroxy...
|
|
WO/2007/004077A2 |
The invention includes an improved process for producing tamsulosin comprising reacting 5-(2-aminopropyl)-2-methoxybenzenesulfonamide with 2-(o-ethoxyphenoxy)ethyl bromide in an organic phosphite solvent to obtain tamsulosin. Optically p...
|
|
WO/2007/002172A2 |
Described are novel protease inhibitors and methods for using said protease inhibitors in the treatment of human immunodeficiency virus (HIV) infection.
|
|
WO/2006/134212A2 |
The invention relates to a process for the production of tamsulosin hydrochloride crystals where the crystal size distribution is controlled by controlling the temperature where hydrochloric acid is added to the reaction mixture.
|
|
WO/2006/135648A2 |
Methods for treating an animal for endo and/or ecto parasite infestation and/or for protecting an animal from endo and/or ecto parasite infestation using N-phenyl-1,1,1-trifluoromethanesulfonamide compounds are provided, together with me...
|
|
WO/2006/135694A2 |
Disclosed herein are novel aromatic-containing compounds and methods for using various aromatic-containing compounds for treatment and prevention of diseases and disorders related to the Urotensin II receptor.
|
|
WO/2006/131757A1 |
The present invention relates to a process for preparing certain sulphonamide intermediates useful in the preparation of HIV inhibitors and to the crystal forms thereof.
|
|
WO/2006/131452A1 |
The invention is concerned with novel sulfonamide derivatives of Formula (I); wherein R2, R3, R4, A, X, Y1, Y2, Y3, Y4 and Z1 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters the...
|
|
WO/2006/132811A2 |
The present invention relates to AMPA receptor potentiators of Formula (I), formulations comprising them, methods for their use, and intermediates useful for their preparation.
|
|
WO2006097817A9 |
This invention provides a compound of the formula (I) or a pharmaceutically acceptable salt or solvate thereof. These compounds are useful for the treatment of disease conditions caused by overactivation of VR1 receptor such of pain, or ...
|
